RemeGen Co

RemeGen Co ROIC

The Return on Invested Capital (ROIC) of RemeGen Co (688331.SS) as of Oct 26, 2026 is 18.70 %. In the previous year, Return on Invested Capital (ROIC) was -31.53 % — a change of -159.29% (higher).

ROIC

18.70 %

YoY

-159.29%

Last updated:

Return on Invested Capital (ROIC) of RemeGen Co is 2025 18.70 % . Return on Invested Capital (ROIC) of RemeGen Co was 2024 -31.53 % . It decreases by -159.29% higher compared to the previous year.

The RemeGen Co ROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROIC
Date
ROIC
Jan 1, 2018
-74.04 CNY
Jan 1, 2019
-102.09 CNY
Jan 1, 2020
-18.40 CNY
Jan 1, 2021
7.78 CNY
Jan 1, 2022
-19.41 CNY
Jan 1, 2023
-32.17 CNY
Jan 1, 2024
-31.53 CNY
Jan 1, 2025
18.70 CNY
The RemeGen Co ROIC history
YEARROICYoY
18.70 %-159.29%
-31.53 %-1.99%
-32.17 %+65.73%
-19.41 %-349.40%
7.78 %-142.30%
-18.40 %-81.98%
-102.09 %+37.89%
-74.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RemeGen Co Stock analysis

What does RemeGen Co do? RemeGen Co Ltd generates revenue by researching, developing, and manufacturing innovative biopharmaceuticals, specifically focusing on therapeutic antibody drugs. The company's product portfolio includes tetacept (RC18), veldicitumab (RC48), and a dual-target fusion protein (RC28). These products are designed to treat major diseases such as oncology, autoimmune diseases, and ophthalmology. The firm operates primarily in the domestic market within China, where it commercializes its discoveries. Its business model relies on the development of various antibody types, including antibody drug conjugates (ADCs), antibody fusion proteins, monoclonal antibodies, and bispecific antibodies. This focus allows the company to address significant medical needs through its specialized therapeutic offerings. RemeGen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RemeGen Co stock

Return on Invested Capital (ROIC) of RemeGen Co is 18.70 % in 2025.

Return on Invested Capital (ROIC) of RemeGen Co changed from -31.53 % to 18.70 %, representing a -159.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Invested Capital (ROIC) RemeGen Co since 2006 – with annual values, charts, and detailed analysis.

ROIC measures how effectively a company uses its invested capital to generate profits. A ROIC above the cost of capital creates shareholder value.

ROIC = NOPAT / Invested Capital

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Invested Capital (ROIC)'s RemeGen Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Invested Capital (ROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Invested Capital (ROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — RemeGen Co

All Key Metrics — RemeGen Co